Invicta Diagnostic IPO is to open on December 1, 2025. It is a SME IPO that will raise ₹28.12 crores. The Invicta Diagnostic IPO price band is fixed at ₹80 to ₹85 with a market lot of 3,200 Shares.
Invicta Diagnostic IPO GMP Live Rates day by day with Kostak rates.
| Date | IPO GMP | GMP Trend | Gain |
| 5 Dec | ₹- | – | -% |
| 4 Dec | ₹- | – | -% |
| 3 Dec | ₹3 |  | 3.52% |
Invicta Diagnostic IPO Details
| IPO Open Date | December 1, 2025 |
| IPO Close Date | December 3, 2025 |
| Face Value | ₹10 Per Equity Share |
| IPO Price Band | ₹80 to ₹85 Per Share |
| Issue Size | Approx ₹28.12 Crores |
| Fresh Issue | Approx ₹28.12 Crores |
| Issue Type | Book Built Issue |
| IPO Listing | NSE SME |
| DRHP Draft Prospectus |  |
| RHP Draft Prospectus | |
Invicta Diagnostic IPO Dates
| IPO Open Date: | December 1, 2025 |
| IPO Close Date: | December 3, 2025 |
| Basis of Allotment: | December 4, 2025 |
| Refunds: | December 5, 2025 |
| Credit to Demat Account: | December 5, 2025 |
| IPO Listing Date: | December 8, 2025 |
| IPO Bidding Cut-off Time: | December 3, 2025 – 5 PM |
Business Overview
Invicta Diagnostic Limited has been engaged in providing radiology and pathology solutions since January 2021. Under the brand ‘PC Diagnostics’, the company provides pathology and radiology tests, including imaging and teleradiology. Invicta runs 7 diagnostic centres and a central lab across Mumbai, Maharashtra. As of October 31, 2025, the company provides a wide range of medical specialty tests, including 60 routine and 487 specialized pathology tests, along with 96 basic and 130 advanced radiology tests.
The company offers a wide range of pathology and radiology tests, such as biochemistry and clinical pathology, cytogenetics, and high-end molecular diagnostics, basic echocardiograms, X-rays, ultrasounds, CT scans, MRI scans, and PET CT scans. Moreover, the company also runs a hub-and-spoke model in the Mumbai Metropolitan Region with a main hub in Thane West, 3 additional hubs in Bhayandar, Byculla, and Marol, and 3 spokes in Lower Parel, Sewri, and Kalwa.
Invicta Diagnostic IPO GMP aka Grey Market Premium FAQs:
What is Invicta Diagnostic IPO GMP Today?
What is Invicta Diagnostic IPO Expected Returns?
Disclaimer:
- IPO Grey Market Premium (Invicta Diagnostic IPO GMP) mention is valid for the specific date as mentioned in the header.
- We are not buying and selling IPO forms on IPO Grey Market.
- Kostak Rate is the premium one gets by selling his/her IPO application (in an off-market transaction) to someone else even before allotment or listing of the issue.
- Do not subscribe for IPO by just seeing the premium Price as it may change anytime before listing. Subscribe only considering the fundamentals of the companies.
